BioSpace News Archive

Capital Rx, a next generation pharmacy benefits manager, announced the launch of its Clearinghouse Model, the first major innovation in the way prescriptions are priced for over three decades.

CAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the initiation of two clinical trials for IPI-549, a first-in-class, oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma.

Summit Diagnostics now offers a new Validity Screen which now proves that the specimens being tested are real, unadulterated and not replaced with synthetics.

Company to Demonstrate FDA Approved ClearUP Sinus Pain Relief

Finding demonstrates impact, reach of groundbreaking medical research at Northwell Health

Peer-Reviewed Study Suggests AI Solution can be More Effective than Traditional Models to Identify Patients at Risk of Death or Readmission for Congestive Heart Failure

This Breakthrough Device designation is the first designation for a non-invasive diagnostic test that is designed to detect pre-cancerous polyps, as well as early-stage carcinomas, with the potential to aid in the interception of carcinogenesis and prevention of colorectal cancer

Many individuals struggling with self-harm often find themselves stuck in a cycle. The cycle impairs how they function in daily life and can become an addiction.

Sonendo®, Inc., the developer of the GentleWave® System, a breakthrough technology for the dental marketplace, today announced that President and CEO, Bjarne Bergheim, will present at the Baird 2019 Global Healthcare Conference on Thursday, Sept 5, 2019, 11:25 a.m. EDT.

New intra-articular injection route will expand the suite of drug delivery options available in GastroPlus®